Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel Free CTXR Stock Alerts

Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History

Citius Pharmaceuticals logo
$1.15 -0.04 (-3.36%)
Closing price 04:00 PM Eastern
Extended Trading
$1.16 +0.01 (+0.87%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Citius Pharmaceuticals Stock Price Performance

The Citius Pharmaceuticals (CTXR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 91.09%, with a year-to-date return of -71.25%. In the past month, the stock has decreased 8.73%, reflecting recent market activity.

As of the latest close, Citius Pharmaceuticals traded at $1.19 with a market cap of $20.24 million and volume of 323,251 shares. Five years ago, the stock traded at a split-adjusted price of $25.00, representing a 95.40% decrease over that period. At the time, it had a market cap of $55.48 million and a volume of 8,906 shares.

Receive CTXR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-3.36%
1 Month
Performance
-8.73%
3 Month
Performance
-4.17%
Year-To-Date
Performance
-71.25%
1 Year
Performance
-91.09%
5 Year
Performance
-95.40%

CTXR Stock Chart for Thursday, September, 25, 2025

CTXR Chart by TradingView

Citius Pharmaceuticals Stock Price History

Export to Excel
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/25/2025$1.19$1.15
-3.36%		$1.19$1.14253,134 shs$19.56 million
09/24/2025$1.15$1.19
+3.48%		$1.20$1.16323,251 shs$20.24 million
09/23/2025$1.16$1.15
-0.86%		$1.18$1.15221,704 shs$19.56 million
09/22/2025$1.19$1.16
-2.52%		$1.21$1.15357,514 shs$19.73 million
09/19/2025$1.17$1.19
+1.71%		$1.19$1.16285,310 shs$20.24 million
09/18/2025$1.18$1.17
-0.85%		$1.23$1.17280,479 shs$19.90 million
09/17/2025$1.17$1.18
+0.85%		$1.23$1.17194,625 shs$20.07 million
09/16/2025$1.14$1.17
+2.63%		$1.20$1.15181,776 shs$19.90 million
09/15/2025$1.21$1.14
-5.79%		$1.19$1.13288,749 shs$19.39 million
09/12/2025$1.20$1.21
+0.83%		$1.21$1.18159,960 shs$20.58 million
09/11/2025$1.21$1.20
-0.83%		$1.25$1.19188,363 shs$20.41 million
09/10/2025$1.21$1.21$1.23$1.18123,136 shs$20.59 million
09/09/2025$1.22$1.21
-0.82%		$1.22$1.17184,354 shs$20.58 million
09/08/2025$1.23$1.22
-0.81%		$1.23$1.16215,733 shs$20.75 million
09/05/2025$1.15$1.23
+6.96%		$1.23$1.13270,117 shs$20.92 million
09/04/2025$1.22$1.15
-5.74%		$1.24$1.10555,375 shs$19.56 million
09/03/2025$1.29$1.22
-5.43%		$1.30$1.19399,167 shs$20.75 million
09/02/2025$1.33$1.29
-3.01%		$1.31$1.26320,921 shs$21.94 million
09/01/2025$1.33$1.33$1.57$1.312.36 million shs$22.63 million
08/29/2025$1.40$1.33
-5.00%		$1.57$1.312.36 million shs$22.63 million
08/28/2025$1.37$1.40
+2.19%		$1.40$1.33184,616 shs$23.81 million
08/27/2025$1.32$1.37
+3.79%		$1.39$1.31208,758 shs$23.30 million
08/26/2025$1.26$1.32
+4.76%		$1.32$1.26205,735 shs$22.46 million
08/25/2025$1.35$1.26
-6.67%		$1.35$1.23482,116 shs$21.43 million
Related Companies

This page (NASDAQ:CTXR) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsoredtc pixel
Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel